What is the recommended dose of sertraline (Selective Serotonin Reuptake Inhibitor) for Obsessive-Compulsive Disorder (OCD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline Dosing for Obsessive-Compulsive Disorder (OCD)

For adults with OCD, sertraline should be initiated at 50 mg once daily and can be increased up to a maximum of 200 mg daily, with dose adjustments occurring at intervals of at least one week. 1

Initial Dosing

  • For adults with OCD, start with 50 mg once daily 1
  • For children (ages 6-12), start with 25 mg once daily 1
  • For adolescents (ages 13-17), start with 50 mg once daily 1
  • Sertraline can be administered in the morning or evening 1

Dose Titration

  • Patients not responding to initial doses may benefit from dose increases up to a maximum of 200 mg/day 1
  • Dose changes should not occur at intervals of less than 1 week due to sertraline's 24-hour elimination half-life 1
  • Higher doses of SSRIs are typically used for OCD compared to other anxiety disorders or depression 2
  • Higher doses are associated with greater treatment efficacy but also higher rates of adverse effects 2

Treatment Duration

  • An 8-12 week trial is recommended to determine efficacy 2
  • Significant improvement in OCD symptoms may be observed within the first 2 weeks of treatment, with clinically significant improvement by week 6 and maximal improvement by week 12 or later 2
  • After achieving remission, maintenance treatment should continue for a minimum of 12-24 months 2
  • Longer treatment may be necessary in many patients due to risk of relapse after discontinuation 2

Special Populations

  • For patients with liver impairment, a lower or less frequent dose should be used 1
  • For children with OCD, their lower body weights should be considered when advancing the dose to avoid excess dosing 1
  • Elderly patients may require lower doses due to approximately 40% lower plasma clearance 1

Efficacy Considerations

  • In clinical trials, patients were dosed in a range of 25-200 mg/day, with mean doses for completers ranging from 178-186 mg/day 1
  • Studies have shown that sertraline is superior to placebo in reducing OCD symptoms as measured by the Yale-Brown Obsessive-Compulsive Scale 1, 3
  • Some evidence suggests that a rapid titration regimen (reaching 150 mg/day by day 5) may provide earlier symptom relief compared to slower titration, with similar tolerability 4

Adverse Effects and Monitoring

  • Common side effects include dry mouth, nausea, diarrhea, headache, somnolence, insomnia, dizziness, and sexual dysfunction 2
  • Potentially serious adverse effects include suicidal thinking (particularly in young adults), behavioral activation/agitation, hypomania, seizures, abnormal bleeding, and serotonin syndrome 2
  • Close monitoring for suicidality is recommended, especially in the first months of treatment and following dosage adjustments 2
  • Behavioral activation/agitation may occur early in treatment, with dose increases, or with concomitant administration of drugs that inhibit the metabolism of SSRIs 2

Treatment Resistance

  • If patients fail to respond adequately to sertraline, options include:
    • Switching to another SSRI 2
    • Trying clomipramine (a tricyclic antidepressant) 2
    • Augmentation with antipsychotics or glutamatergic agents 2
    • Adding cognitive-behavioral therapy (CBT) if available 2

Remember that SSRIs and cognitive-behavioral therapy are both first-line treatments for OCD, and combining them may provide additional benefit for patients with inadequate response to either treatment alone 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.